We recently discovered that breast cancer cells that migrated to the bone carry the PRL-receptor (PRLR) and that PRL signaling to breast cancer cells advances osteolytic osteoclast differentiation via the production of a soluble factor that modulates the bone [1]. The gene discussed is PRL; the disease is breast carcinoma.